Apolipoprotein Deficiency and Chronic Liver Disease

Journal of Association of Physicians of India

Volumn 47, Issue 2, 1999, Pages 274-278

  Shah, S S ^a   Desai, H G ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042131458     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Ginsberg HN, Goldberg IJ. Disoiders of Lipoprotein metabolism. In : Fauci AS, Braunwald E, Isselbacher KJ Ed., Harrison's Principles of Internal Medicine, 14th ed. New York : McGraw Hill. 1998; 2138-49.
2. Assmann G, Schmitz G, Brewer BH Jr. Familial high density lipoprotein deficiency : Tangier disease. In : Sciver CR, Beaudet AL, Sly WS, Valle D Ed., The metabolic basis of inherited disease. 6th ed. New York : McGraw Hill. 1989; 1267-82.
3. Hoffman HN, Fredrickson DS. Tangier disease (familial high density lipoprotein deficiency) : clinical and genetic features in two adults. Am J Med 1965; 39 : 582-93.
4. Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, Goodman HC. Tangier disease - Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 1961; 55 : 1016-31.
5. Schaeffer EJ, Blum CB, Levy RI, et al. Metabolism of high density lipoprotein apolipoproteins in Tangier disease. N Engl J Med 1978; 299 : 905-10.
6. Assmann G, Simantke O, Schaefer HE, Smootz E. Characterisation of high density lipoproteins in patients heterozygous for Tangier disease. J Clin Invest 1977; 60 : 1025-35.
7. McIntyre N. The liver in some other hereditary diseases and in disorders of plasma lipoproteins. In : McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J Ed., Oxford textbook of clinical hepatology, Oxford : Oxford University Press. 1991; 991-4.
8. Kayden HJ, Bessis M. Morphology of normal erythrocyte and acanthocyte using Nomarski optics and the scanning electron microscope. Blood 1970; 35 : 427-36.
9. Ways P, Reed CF, Hanahan DJ. Red cell and plasma lipids in acanthocytosis. J Clin Invest 1963; 42 : 1248-60.
10. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the β apolipoprotein. In : Sciver CR, Beaudet AL, Sly WS, Valle D Ed., The metabolic basis of inherited disease. 6th ed. New York : McGraw Hill. 1989; 1139-64.
11. Schwartz JF, Rowland LP, Eder H, et al. Basen - Kornzweig syndrome : Deficiency of serum beta-lipoprotein. Arch Neurol 1963; 8 : 438-54.
12. Partin JS, Partin JC, Schuberto WK, McAdams AJ. Liver ultrastructure in abetalipoproteinemia : evolution of micronodular cirrhosis. Gastroenterology 1974; 67 : 107-18.
13. Iselbacher KJ, Scheig R, Plotkin GR, Caufield JB. Congenital betalipoprotein deficiency : An inherited disorder involving a defect in the absorption and transport of lipids. Medicine 1964; 43 : 347-61.
14. Illingworth DR, Connor WE, Miller RG. Abetalipoproteinemia. Report of two cases and review of therapy. Arch Neurol 1980; 37 : 659-62.
15. Gotto AM, Levy RI, John K, Fredrickson DS. On the nature of the protein defect in abetalipoproteinemia. N Engl J Med 1971; 284 : 813-8.
16. Scanu AM, Aggerbeck LP, Kruski AW, Lim CT, Kayden HJ. A study of the abnormal lipoproteins in abetalipoproteinemia. J Clin Invest 1974; 53 : 440-53.
17. Levy RI, Fredrickson DS, Laster L. The lipoproteins and lipid transport in abetalipoproteinemia. J Clin Invest 1966; 45 : 531-41.
18. Mehta NN, Desai HG. Persistent transaminase elevation due to heterozygous (familial) apolipoprotein B deficiency. Indian J Gastroenterol 1997; 16 : 158-9.
19. Wishingrad M, Paaso B, Garcia G. Fatty liver due to heterozygous hypolipoproteinemia. Am J Gastroenterol 1994; 89 : 1107-8.
20. Hagve TA, Myrseth LE, Schrumpf E. Liver steatosis in hypobetalipoproteinemia. J Hepatol 1991; 13 : 104-11.
21. Fosbrooke A, Choksey S, Wharton B. Familial hypo β-lipoproteinemia. Arch Dis Child 1973; 48 : 729-32.
22. Muller P, Fellin R, Lambrecht J, et al. Hypertriglyceridemia secondary to liver disease. Europ J Clin Invest 1974; 4 : 419-28.
23. Papadopoulos NM, Charles MA. Serum lipoprotein patterns in liver disease. Proc Soc Expl Biol Med 1970; 134 : 797-9.
24. Thalassinos N, Hatzionnou J, Scliros P, et al. Plasma α-lipoprotein pattern in acute viral hepatitis. Dig Dis 1975; 20 : 148-55.
25. Johansson BG, Medus A. Increase in plasma alpha-lipoproteins in chronic alcoholics after acute abuse. Acta Med Scand 1974; 195 : 273-7
26. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319 : 267-73.
27. Borowsky SA, Perlow W, Baraona E, Lieber CS. Relationship of alcoholic hypertriglyceridemia to stage of liver disease and dietary lipid. Dig Dis Sci 1980; 25 : 22-7.
28. Baraona E, Lieber CS. Effects of ethanol on lipid metabolism. J Lipid Res 1979; 20 : 289-315.
29. Mathurin P, Vidaud D, Viduad M, et al. Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease. Hepatology 1996; 23 : 44-51.
30. Nayak SS, Ramani A, Kamath SS, Kundaje GN, Ajoor AR. Serum apoproteins A and B and the lecithin : cholesteryl acyl transferase activities in liver cirrhosis and hepatic coma patients. Biochem Med Metabol Biol 1988; 40 : 299-304.
31. Zoli M, Cordiani MR, Bonazzi C, et al. Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991; 86 : 1508-13.
32. Cordova C, Musca A, Violi F, Alessandri C, Iuliano L. Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhosis patients. Clin Chim Acta 1984; 137 : 61-6.
33. Luoma PV, Sotaniemi EA, Pelkonen RO, Arranto A, Ehnholm C. Plasma high density lipoproteins and hepatic microsomal enzyme induction. Eur J Clin Pharmacol 1982; 23 : 275-82.
34. Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach. Hepatogastroenterol 1985; 32 : 270-2.
35. Malmendier CL, Mailier EL, Amerijcxx JP, Fischer ML. Plasma levels of apolipoproteins A-I, A-II and B in alcoholism. Relation to the degree of histological liver damage and to liver function tests. Hepatogastroenterol 1983; 30 : 236-9.
36. Christensen E, Schlichting P, Fauerholdt L, et al. Changes of laboratory variables with time in cirrhosis : prognostic and therapeutic significance. Hepatology 1985; 5 : 843-53.
37. Poynard T, Abella A, Pignon JP. Apolipoprotein AI and alcoholic liver disease. Hepatology 1986; 6 : 1391-5.
38. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipids and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997; 157 : 792-6.
39. Tietge UJ, Boker KH, Bahr MJ, et al. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterol 1998; 45 : 2255-60.
40. Ciccarese M, Tonolo G, Brizzi P, et al. Serum apolipoprotein (a) concentrations and Apo (a) phenotypes in patients with liver cirrhosis. Am J Gastroenterol 1998; 93 : 1505-9.
41. Sposito AC, Vinagre CG, Pandullo FL, Mies S, Raia S, Ramires JA. Apolipoprotein and lipid abnormalities in chronic liver disease. Brazilian J Med Biol Res 1997; 30 : 1287-90.
42. Camps J, Pizarro I, Prats E, et al. Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse : effects of alcohol intake cessation. J Hepatol 1994; 21 : 704-9.
43. Harry DS, McIntyre N. Plasma lipids and lipoproteins. In : McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J Ed., Oxford textbook of clinical hepatology. Oxford : Oxford University Press. 1991; 143-57.
44. Day RC, Havey DS, Owen JS, McIntyre N. Plasma lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease. Clinical Science 1997; 56 : 575-83.
45. Floren CH, Franzen J, Albers JJ. Apolipoprotein A-I in liver disease. Scand J Gastro 1987; 22 : 454-8.
46. Iglesias A, Arranz M, Alvarez JJ, et al. Cholesteryl ester transfer activity in liver disease and cholestasis and its relation with fatty acid composition of lipoprotein lipid. Clinica Chimica Acta 1996; 248 : 157-74.
47. Crippin JS, Lindor KD, Jorgensen R, et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis : what is the risk? Hepatology 1992; 15 : 858-62.
48. Edwards CM, Otal MP, Stacpoole PW. Lipoprotein-X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells. Metabolism : Clinical and Experimental 1993; 42 : 807-13.
49. Rosenson RS, Baker AL, Chow MJ, Hay RV. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990; 98 : 1351-7.
50. Busnach G, Franceschini G, Chiesa G, et al. Impaired efficacy of selective LDL-apheresis in primary biliary cirrhosis. Int J Artif Organs 1991; 14 : 246-50.
51. Magnani HN, Alaupovic P. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extrahepatic obstructive jaundice and intrahepatic diseases. Gastroenterology 1976; 71 : 87-93.